85 related articles for article (PubMed ID: 21094856)
1. Effects and mechanisms of tacrolimus on development of murine Th17 cells.
Zhang XJ; Kang YD; Xiao L; Li RD; Ding GS; Wang ZX; Fu ZR
Transplant Proc; 2010 Nov; 42(9):3779-83. PubMed ID: 21094856
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive effects of DTCM-G, a novel inhibitor of the mTOR downstream signaling pathway.
Shibasaki S; Yamashita K; Goto R; Wakayama K; Tsunetoshi Y; Zaitsu M; Igarashi R; Haga S; Ozaki M; Umezawa K; Todo S
Transplantation; 2013 Feb; 95(4):542-50. PubMed ID: 23269193
[TBL] [Abstract][Full Text] [Related]
3. Triptolide inhibits the differentiation of Th17 cells and suppresses collagen-induced arthritis.
Wang Y; Jia L; Wu CY
Scand J Immunol; 2008 Oct; 68(4):383-90. PubMed ID: 18782267
[TBL] [Abstract][Full Text] [Related]
4. Impact of mycophenolic acid and tacrolimus on Th17-related immune response.
Abadja F; Atemkeng S; Alamartine E; Berthoux F; Mariat C
Transplantation; 2011 Aug; 92(4):396-403. PubMed ID: 21818055
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
[TBL] [Abstract][Full Text] [Related]
6. Critical role of regulatory T cells in Th17-mediated minor antigen-disparate rejection.
Vokaer B; Van Rompaey N; Lemaître PH; Lhommé F; Kubjak C; Benghiat FS; Iwakura Y; Petein M; Field KA; Goldman M; Le Moine A; Charbonnier LM
J Immunol; 2010 Sep; 185(6):3417-25. PubMed ID: 20733201
[TBL] [Abstract][Full Text] [Related]
7. IFN-beta inhibits human Th17 cell differentiation.
Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
[TBL] [Abstract][Full Text] [Related]
8. 1α,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells.
Ikeda U; Wakita D; Ohkuri T; Chamoto K; Kitamura H; Iwakura Y; Nishimura T
Immunol Lett; 2010 Nov; 134(1):7-16. PubMed ID: 20655952
[TBL] [Abstract][Full Text] [Related]
9. A pathogenic role of IL- 17 at the early stage of corneal allograft rejection.
Chen H; Wang W; Xie H; Xu X; Wu J; Jiang Z; Zhang M; Zhou L; Zheng S
Transpl Immunol; 2009 Jul; 21(3):155-61. PubMed ID: 19358887
[TBL] [Abstract][Full Text] [Related]
10. Effect of tacrolimus derivatives on immunosuppression.
Choi D; Cho H
Arch Pharm Res; 2009 Apr; 32(4):549-57. PubMed ID: 19407973
[TBL] [Abstract][Full Text] [Related]
11. Küpffer cells promote acute rejection via induction of Th17 differentiation in rat liver allografts.
Xie X; Ye Y; Zhou L; Jiang G; Xie H; Feng X; He Y; Zheng S
Transplant Proc; 2010 Nov; 42(9):3784-92. PubMed ID: 21094857
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin.
Hoogduijn MJ; Crop MJ; Korevaar SS; Peeters AM; Eijken M; Maat LP; Balk AH; Weimar W; Baan CC
Transplantation; 2008 Nov; 86(9):1283-91. PubMed ID: 19005411
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice.
Ma A; Qi S; Wang Z; Massicotte E; Dupuis M; Daloze P; Chen H
Int Immunopharmacol; 2009 May; 9(5):553-63. PubMed ID: 19539558
[TBL] [Abstract][Full Text] [Related]
14. Regulation of gut inflammation and th17 cell response by interleukin-21.
Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
[TBL] [Abstract][Full Text] [Related]
15. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
Rintala JM; Savikko J; Rintala SE; von Willebrand E
Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of T Helper Cell Differentiation by Tacrolimus or Sirolimus Results in Reduced B-Cell Activation: Effects on T Follicular Helper Cells.
Kraaijeveld R; Li Y; Yan L; de Leur K; Dieterich M; Peeters AMA; Wang L; Shi Y; Baan CC
Transplant Proc; 2019 Dec; 51(10):3463-3473. PubMed ID: 31733794
[TBL] [Abstract][Full Text] [Related]
17. FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line.
Wang SC; Zeevi A; Jordan ML; Simmons RL; Tweardy DJ
Transplant Proc; 1991 Dec; 23(6):2920-2. PubMed ID: 1721312
[No Abstract] [Full Text] [Related]
18. Effects of resveratrol on Th17 cell-related immune responses under tacrolimus-based immunosuppression.
Doh KC; Kim BM; Kim KW; Chung BH; Yang CW
BMC Complement Altern Med; 2019 Mar; 19(1):54. PubMed ID: 30832648
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and the balance of Treg and Th17 cells in transplant rejection and tolerance.
Hanidziar D; Koulmanda M
Curr Opin Organ Transplant; 2010 Aug; 15(4):411-5. PubMed ID: 20613526
[TBL] [Abstract][Full Text] [Related]
20. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
